Platelet and Plasma markets Share Trends Analysis Growth: America's Blood Centers, American Red Cross, Blood Centers of America, Brazilian Red Cross, Canadian Red Cross, European Blood Alliance, French Red Cross Foundation, German Red Cross
Increasing blood transfusion rates in Europe will drive the global platelet and plasma market growth over the forecast period. Blood transfusion process is primarily done to isolate the desired blood components such as red blood cells, plasma, platelets and other vital components of the blood. Government initiatives to create awareness regarding source plasma collection as well as use of lifesaving plasma protein therapies in rare diseases will positively impact the market growth. Advancements in healthcare infrastructure coupled with increasing number of blood transfusions will directly impact growth of platelets and plasma market in coming years.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2737
Advent of technologically advanced platelet and plasma products is another major driver that will augment the market growth. Use of platelets and plasma in treatment of rare, debilitating, life-threatening conditions and chronic diseases such as Hepatitis B heavily influences growth of the market. Plasma derived from blood can be used in treating rare diseases wherein no other alternative treatment is available. For instance, use of plasma for treatment of Ebola virus during its outbreak in West Africa. Aforementioned factors will augment the market growth during the forecast period.
However, strict regulations regarding plasma collection will impede the growth of platelets and plasma market to a certain extent during the forecast period. Moreover, low affordability in developing economies such as APAC and Latin America owing to high costs will further impact the market growth.
Platelet segment accounted for the largest market share with a revenue of USD 3.6 billion in 2017 and will continue to dominate the industry over the forecast period. The reason can be attributed to increasing adoption of advanced technologies for the treatment of various diseases. Platelets are used in various surgical procedures due to its vivid therapeutic and prophylactic applications. According to the World Federation of Hemophilia (WFH), in 2016, around 2,95,866 people suffered from bleeding disorders wherein 1,84,723 accounted for haemophilia.
Increasing demand of platelets for treatment of haemophilia and other blood disorders will fuel the segment growth over the forecast period. Moreover, various initiatives by government and other organizations to encourage blood donation among people and adoption of advanced technologies in developed and developing economies will further boost the industry growth.
Plasma segment is predicted to witness significant growth rate of 2.1% CAGR over the analysis period. The growth is attributed to rising incidences of chronic diseases such as autoimmune diseases, hereditary angioedema and other rare diseases. Plasma is used for treatment of various rare diseases in case of unavailability of any specific treatment, drugs or vaccines.Moreover, plasma is also used in treatment of neurological disorders such as multiple sclerosis, trauma, burns, shock and other medical emergencies. Growing prevalence of chronic diseases, developments in healthcare infrastructure and supportive government funding in developing economies are projected to augment the market growth over the forecast period.
Browse Full Report Details @ https://www.gminsights.com/industry-analysis/platelet-and-plasma-market
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
America's Blood Centers
American Red Cross
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross Foundation
German Red Cross
Indian Red Cross Society (IRCS)
Italian Red Cross
JAPANESE RED CROSS SOCIETY
Red Cross Society of China
Saudi Red Crescent Authority
South African Red Cross Society (SARCS)
Spanish Red Cross
Liver disease segment accounted for more than USD 595 million in 2017 and is projected to witness lucrative growth during the forthcoming years. Prevalence of liver disease such as cirrhosis, hepatocellular carcinoma, hepatitis and other autoimmune diseases is high in many developed as well as developing countries. According to Paris Hepatology Conference, chronic liver diseases (CLD) accounted for 18.5% of all diseases in 2017. Moreover, lifestyle changes, increasing alcohol consumption and growing geriatric population base prone to chronic diseases will further fuel the demand for platelets and plasma during the forthcoming years.
Hemorrhage segment is expected to witness significant growth with a CAGR of 2.2% over the analysis timeframe owing to the rising number of hemorrhage cases across the globe. World Health Organization estimated that haemorrhage accounts for more than 7.5 million deaths across the globe. Furthermore, obstetric haemorrhage is one of the leading causes of maternal mortality, accounting for around 35% of maternal deaths annually. Increasing prevalence of hemorrhage, growing disposable income as well as growing demand for plasma and its derivatives for treatment of hemorrhage will augment the market growth over the forecast period.
Hospitals segment dominated the platelets and plasma market in 2017 and is estimated to grow at 2.2% CAGR during the coming years. Increasing demand for platelets and plasma for treatment of various diseases such as anaemia, haemophilia and other blood disorders will boost the market growth. Availability of high-cost devices in hospitals, developments in healthcare infrastructure as well as fair reimbursement policies for procedures performed in hospitals will drive the platelets and plasma industry growth throughout the analysis period.
Ambulatory Surgical Centres (ASCs) accounted for 28.1% of the revenue share in 2017. The segment is estimated to witness lucrative growth in the coming years owing to growing inclination of people towards ambulatory surgeries. The benefits offered by ASCs such as short hospital stay, reduced risks of hospital acquired infection as well as well equipped facilities will accelerate the growth of platelets and plasma market during the analysis timeframe.
North America Platelet and Plasma Market accounted for the highest revenue of over USD 2.1 billion in 2017 and is projected to grow at a significant rate during the forecast period. The growth is attributed to the increasing cases of cancer, obesity, cardiac diseases, neurological disorders and other chronic diseases. Furthermore, American Red Cross undertakes various initiatives for increasing awareness regarding importance of blood donation. Blood donation systems in North America are based on a mixed system of non-compensated as well as compensated donations. Moreover, high demand for advanced technologies coupled with availability of advanced healthcare infrastructure will augment the regional growth during the forecast period.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2737
Europe region is expected to witness remarkable growth with a CAGR of 1.9% during the forthcoming years due to high number of blood transfusions in Europe. Plasma and its derivatives are used for manufacturing medicinal products for patients in need. Blood transfusion is in high demand amongst the German population undergoing chemotherapy treatment owing to rising prevalence of cancer. Moreover, growing incidences of road accidents as well as increasing cases of minor muscle injuries due to athletics and other sports will accelerate the market growth in foreseeable future.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Platelet and Plasma markets Share Trends Analysis Growth: America's Blood Centers, American Red Cross, Blood Centers of America, Brazilian Red Cross, Canadian Red Cross, European Blood Alliance, French Red Cross Foundation, German Red Cross here
News-ID: 1604835 • Views: 701
More Releases from Global Market Insights, Inc
Point of Care Ultrasound Market Outlook 2021-2025 | Analogic, Canon Medical Syst …
Growing demand for fast and accurate diagnostic tools is expected to drive point of care ultrasound market growth in the ensuing years. Point-of-care ultrasound (POCUS) has become a standard tool in the emergency department, as it answers to specific clinical queries that narrow differentials, guide clinical therapy, and direct consultations and disposition. Recent technological advancements have led to the development of miniature POCUS that range from stationary high-end systems to small
Medical Tourism Market Forecast 2027 By Top Players Asklepios, KPJ Healthcare Bh …
Medical Tourism Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. Every year millions of people travel abroad seeking medical treatment and efficient surgical procedures such as cosmetic surgery, cardiovascular surgery, orthopedic and dental surgery which is referred to
Medical X-ray Market Outlook 2021-2027 | Top Players Siemens Healthcare, GE Heal …
Medical X-ray Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. Researchers at Northwestern University have designed a new AI-based platform that analyses lung X-rays and detects COVID-19. The machine-learning (ML) algorithm, named DeepCOVID-XR, was able to outperform a
Biosensors Market 2021 by Top Industry Players Abbott Laboratories, Bio-Rad Inte …
Biosensors Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. Rising incidences of several serious disorders among the global population has evoked the need to detect these at early stages in order to obtain appropriate treatment on time. This
More Releases for Red
RED OAK SOCCER ASSOCIATION RETURNS TO THE CITY OF RED OAK
Inaugural Spring 2020 Season Red Oak, March 9, 2020 - On today's date, the Red Oak Soccer Association along with the City of Red Oak, after 12 years of Red Oak teams playing home soccer games in Glenn Heights and Waxahachie, have come to an agreement allowing the Red Oak Soccer Association to play home games within the city of Red Oak. Beginning this Spring Season, with a start date of March
Platelet and Plasma Market : Illustrious Companies - America’s Blood Centers, …
Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report. Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in
Red Hat Expands Red Hat Developer Program with No-Cost Red Hat Enterprise Linux …
DUBAI, UAE, 3rd April, 2016 – Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, today announced the availability of a no-cost Red Hat Enterprise Linux subscription, available as part of the Red Hat Developer Program. Offered as a self-supported, non-production developer subscription, the Red Hat Enterprise Linux Developer Suite provides developers with a more stable development platform for building enterprise-grade applications and enables a clear
Red Hat Updates Red Hat Academy, Brings Red Hat OpenStack Cloud Technology Educa …
DUBAI, United Arab Emirates, 14th January, 2014 - Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, today announced updates to Red Hat Academy, the company’s open source education program that offers turnkey curriculum materials for educational programs in global secondary and higher education institutions. Red Hat has expanded Red Hat Academy to include content on Red Hat Enterprise Linux OpenStack Platform and Red Hat JBoss
Red Hat Launches Latest Version of Red Hat Enterprise Linux 6
DUBAI, United Arab Emirates - 26th November, 2013 - Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, today announced the general availability of Red Hat Enterprise Linux 6.5, the latest version of Red Hat Enterprise Linux 6. Red Hat Enterprise Linux 6.5 expands Red Hat’s vision of providing an enterprise platform that has the stability to free IT to take on major infrastructure challenges and
Red Hat Releases Red Hat Enterprise Linux 6.2
DUBAI, United Arab Emirates, 11th December, 2011 – Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, today announced the general availability of Red Hat Enterprise Linux 6.2. With this milestone, Red Hat includes many enhancements that deliver benefits spanning multiple areas, including performance and scalability. Red Hat Enterprise Linux 6 operating system achieved the largest multi-core Linux configuration results certified to-date on the two-tier SAP®